Using proton magnetic resonance spectroscopy to identify mild cognitive impairment

International Psychogeriatrics

Volumn 24, Issue 1, 2012, Pages 19-27

  Wang, Tao ^a   Xiao, Shifu ^a   Li, Xia ^a   Ding, Bei ^b   Ling, Huawei ^b   Chen, Kemin ^b   Fang, Yiru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; hippocampus; NAA Cr; posterior cingulate gyri

Indexed keywords

CREATINE; INOSITOL; METHACHOLINE; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PATIENT ASSESSMENT; POSTERIOR CINGULATE; PROTON NUCLEAR MAGNETIC RESONANCE;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING;

EID: 82055203007     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211000962     Document Type: Article

References (28)

1. Ackl, N., Ising, M., Schreiber, Y. A., Atiya, M., Sonntag, A. and Auer, D. P. (2005). Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroscience Letters, 384, 23-28.
2. Adalsteinsson, E., Sullivan, E. V., Kleinhans, N., Spielman, D. M. and Pfefferbaum, A. (2000). Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet, 355, 1696-1697. (Pubitemid 30248487)
3. Catani, M. et al. (2001). (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. NeuroReport, 12, 2315-2317. (Pubitemid 32682179)
4. Chantal, S., Braun, C. M., Bouchard, R. W., Labelle, M. and Boulanger, Y. (2004). Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Research, 1003, 26-35. (Pubitemid 38317081)
5. Chao, L. L. et al. (2005). Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology, 64, 282-289.
6. Choo, I. H. et al. (2010). Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging, 31, 772-779.
7. Fayed, N., D avila, J., Oliveros, A., Castillo, J. and Medrano, J. J. (2008). Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. Academic Radiology, 15, 1089-1098.
8. Fernandez, A. et al. (2005). Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 20, 169-177. (Pubitemid 41191634)
9. Godbolt, A. K. et al. (2006). MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology, 66, 718-722. (Pubitemid 43739827)
10. Huang, W. et al. (2001). Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology, 57, 626-632. (Pubitemid 32782989)
11. Jessen, F. et al. (2001). Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology, 57, 930-932. (Pubitemid 32845528)
12. Jessen, F. et al. (2009). A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology, 72, 1735-1740.
13. Kantarci, K. et al. (2002). Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 14, 198-207. (Pubitemid 36151487)
14. Kantarci, K. et al. (2004). 1H MR spectroscopy in common dementias. Neurology, 63, 1393-1398.
15. Kantarci, K. et al. (2009). Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology, 72, 1519-1525.
16. Katzman, R. et al. (1988). A Chinese version of the Mini-Mental State Examination: impact of illiteracy in a Shanghai dementia survey. Journal of Clinical Epidemiology, 41, 971-978. (Pubitemid 19002065)
17. Krishnan, K. R. et al. (2003). Randomized, placebocontrolled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. American Journal of Psychiatry, 160, 2003-2011. (Pubitemid 39619638)
18. Martinez-Bisbal, M. C., Arana, E., Marti-Bonmati, L., Moll a, E. and Celda, B. (2004). Cognitive impairment: classification by 1H magnetic resonance spectroscopy. European Journal of Neurology, 11, 187-193. (Pubitemid 38373034)
19. Metastasio, A. et al. (2006). Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy. Neurobiology of Aging, 27, 926-932.
20. Modrego, P. J., Fayed, N. and Pina, M. A. (2005). Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. American Journal of Psychiatry, 162, 667-675. (Pubitemid 40489127)
21. Nestor, P. J., Fryer, T. D., Smielewski, P. and Hodges, J. R. (2003). Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Annals of Neurology, 4, 343-351. (Pubitemid 37072036)
22. Pengas, G., Hodges, J. R., Watson, P. and Nestor, P. J. (2010). Focal posterior cingulate atrophy in incipient Alzheimer's disease. Neurobiology of Aging, 31, 25-33.
23. Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183-194. (Pubitemid 39222988)
24. Petersen, R. C.et al. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985-1992. (Pubitemid 33143977)
25. Petersen, R. C. et al. (2010). Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology, 74, 201-209.
26. Simmons, A., Smail, M., Moore, E. and Williams, S. C. (1998). Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain. Magnetic Resonance Imaging, 16, 319-330. (Pubitemid 28264528)
27. Schuff, N. et al. (2002). Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology, 58, 928-935. (Pubitemid 34242070)
28. Zhu, X. et al. (2006). Effects of Alzheimer disease on fronto-parietal brain N- acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Disease and Associated Disorders, 20, 77-85. (Pubitemid 44305906)